{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-questionFirstAnswered.=2019-07-01T16%3A42%3A20.35Z&max-ddpModified.=2019-07-01T17%3A15%3A03.627Z&min-ddpCreated=2019-06-17T19%3A55%3A08.297Z&creator.label=Biography+information+for+Lord+Alton+of+Liverpool&min-ddpModified.=2019-06-25T12%3A23%3A02.008Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-questionFirstAnswered.=2019-07-01T16%3A42%3A20.35Z&max-ddpModified.=2019-07-01T17%3A15%3A03.627Z&min-ddpCreated=2019-06-17T19%3A55%3A08.297Z&creator.label=Biography+information+for+Lord+Alton+of+Liverpool&min-ddpModified.=2019-06-25T12%3A23%3A02.008Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-questionFirstAnswered.=2019-07-01T16%3A42%3A20.35Z&max-ddpModified.=2019-07-01T17%3A15%3A03.627Z&min-ddpCreated=2019-06-17T19%3A55%3A08.297Z&_metadata=all&creator.label=Biography+information+for+Lord+Alton+of+Liverpool&min-ddpModified.=2019-06-25T12%3A23%3A02.008Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&min-questionFirstAnswered.=2019-07-01T16%3A42%3A20.35Z&max-ddpModified.=2019-07-01T17%3A15%3A03.627Z&min-ddpCreated=2019-06-17T19%3A55%3A08.297Z&creator.label=Biography+information+for+Lord+Alton+of+Liverpool&min-ddpModified.=2019-06-25T12%3A23%3A02.008Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-questionFirstAnswered.=2019-07-01T16%3A42%3A20.35Z&max-ddpModified.=2019-07-01T17%3A15%3A03.627Z&min-ddpCreated=2019-06-17T19%3A55%3A08.297Z&creator.label=Biography+information+for+Lord+Alton+of+Liverpool&min-ddpModified.=2019-06-25T12%3A23%3A02.008Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-questionFirstAnswered.=2019-07-01T16%3A42%3A20.35Z&max-ddpModified.=2019-07-01T17%3A15%3A03.627Z&min-ddpCreated=2019-06-17T19%3A55%3A08.297Z&creator.label=Biography+information+for+Lord+Alton+of+Liverpool&min-ddpModified.=2019-06-25T12%3A23%3A02.008Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1135412", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1135412/answer", "answerText" : {"_value" : "
The Human Fertilisation and Embryology Authority (HFEA) Register is not linked to any National Health Service databases or cancer registries; and data from the Register alone would not allow an assessment of the risk to be identified. However, under the Human Fertilisation and Embryology Act (Disclosure of Information for Research Purposes) Regulations 2010, the HFEA may authorise the processing of disclosable protected information contained in the Register for research, in the public interest or in the interests of improving patient care. A recent study by University College London investigated risks of ovarian, breast, and corpus uteri cancer in women treated with Assisted Reproductive Technologies and found no link between the use of ovarian stimulatory drugs and an increased risk of cancer.<\/p>
The HFEA continually updates patient information whenever new clinical information is available. The HFEA is advised by the Scientific and Clinical Advances Advisory Committee on scientific and clinical developments (including research) in assisted conception, embryo research and related areas.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"} } , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"} , "dateOfAnswer" : {"_value" : "2019-07-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-10T15:08:03.363Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-06-27", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF: Breast Cancer"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government, further to the Written Answers by the Parliamentary Under-Secretary of State for Health on 14 July 2014 (HC Deb, col 448W), Earl Howe on 3 December 2014 (HL273), Lord O'Shaughnessy on 3 December 2018 (HL11600), and comments by the Parliamentary Under-Secretary of State for Health on 20 January 2016 (HC Deb, col 623WH), to what extent the Human Fertilisation and Embryology Authority (HFEA) database is linked to (1) NHS databases, and (2) cancer registries; whether data from the register of patients and treatments that is maintained by the HFEA is sufficient to assess the contention that IVF in older women linked to an increased risk of breast cancer; and how the HFEA will ensure that information provided to patients regarding any potential long-term safety implications associated with treatment will include appropriate reference to such risks.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"} } , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"} ], "uin" : "HL16733"} , {"_about" : "http://data.parliament.uk/resources/1135413", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1135413/answer", "answerText" : {"_value" : "
The Human Fertilisation and Embryology Acts 1990 and 2008 do not provide for the regulation of the use or monitoring of medicines used in fertility treatment.<\/p>
Medicines used in fertility treatment are licensed by the Medicines and Healthcare products Regulatory Agency. These medicines may be used in Human Fertilisation and Embryology Authority-licensed clinics or in other settings, for example by general practitioners.<\/p>
Medicine prescribing is a matter of clinical judgement, taking account of the individual patient\u2019s circumstances and professional guidance. It is the duty of every clinician to take into account the welfare and best interest of their patient when deciding on the appropriate treatment for them for any medical condition, in line with General Medical Council\u2019s good medical practice guidance.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"} } , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"} , "dateOfAnswer" : {"_value" : "2019-07-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-10T15:09:39.493Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-06-27", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF: Drugs"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government, further to the Written Answers by the Parliamentary Under-Secretary of State for Health on 14 July 2014 (HC Deb, col 448W), Earl Howe on 3 December 2014 (HL273), and comments by the Parliamentary Under-Secretary of State for Health on 20 January 2016 (HC Deb, col 623WH), how the Human Fertilisation and Embryology Authority (HFEA) ensures that clinics follow National Institute for Health and Care Excellence guidelines on limiting the use of ovulation induction or ovarian stimulation agents to the lowest effective dose and duration of use without collecting information on the identity of drugs used in treatment, the dosage used and the associated regimen for ovarian stimulation at each licensed centre; and what would be needed for the HFEA to regulate the administration of drugs during in vitro fertilisation treatment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"} } , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"} ], "uin" : "HL16734"} , {"_about" : "http://data.parliament.uk/resources/1135060", "AnsweringBody" : [{"_value" : "Home Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1135060/answer", "answerText" : {"_value" : "
All UK Visa applications are considered on their individual merits and in line with the UK Immigration Rules https://www.gov.uk/guidance/immigration-rules/immigration-rules-appendix-v-visitor-rules which set out the requirements to visit the UK. These requirements apply to all visitors to the UK and the onus is on the applicant to demonstrate that they satisfy the immigration rules.<\/p>